Trends in antimicrobial non-susceptibility in methicillin-resistant Staphylococcus aureus from Germany (2004-2011)

F. Schaumburg*, E. A. Idelevich, G. Peters, A. Mellmann, C. von Eiff, K. Becker, M. Abele-Horn, M. Aepfelbacher, F. Albert, A. Anders, W. Bär, B. Beyreiß, G. Bierbaum, U. Bührlen, K. H.U. Borg, K. Claußen, C. Diaz, A. Ditzen, M. Dobonici, U. EignerH. Erichsen, A. Fahr, P. Finzer, U. Frank, A. Friedrich, M. Frosch, G. Funke, S. Gatermann, J. Geisen, W. Hell, M. Herrmann, U. Höffler, E. Jacobs, B. Jansen, D. Jonas, M. Kaase, W. Kalka-Moll, M. Kaulfers, J. K. Knobloch, M. Kresken, B. Körber-Irrgang, M. van der Linden, A. Lommel, C. Lücking, D. Mack, S. Monecke, S. Müller, L. von Müller, M. Trautmann

*Corresponding author for this work
8 Citations (Scopus)

Abstract

We analysed trends in antimicrobial non-susceptibility in methicillin-resistant Staphylococcus aureus (MSRA) from Germany to assess the impact of the changing population structure of MRSA on antimicrobial resistance rates. During two large nationwide multicentre studies in 2004-2005 and 2010-2011, we collected consecutively spa-genotyped MRSA isolates. The increase in non-susceptibility rates for tetracycline and trimethoprim-sulphamethoxazole was associated with the spread of livestock-associated MRSA. A decrease in non-susceptibility rates for aminoglycosides and quinolones affected all major lineages (spa-clonal complexes 003, 008, and 032). All isolated remained susceptible to glycopeptides and linezolid.

Original languageEnglish
JournalClinical Microbiology and Infection
Volume20
Issue number9
Pages (from-to)O554-O557
ISSN1198-743X
DOIs
Publication statusPublished - 01.09.2014

Funding

In addition to the authors, the following persons (in alphabetical order) were participants in the study group: M. Abele-Horn, Würzburg; M. Aepfelbacher, Hamburg; F. Albert, Erlangen; A. Anders, Bochum; W. Bär and B. Beyreiß, Cottbus; G. Bierbaum, Bonn; U. Bührlen, Stuttgart; K. H.-U. Borg, Hamburg; K. Claußen, Hannover; C. Diaz, Köln; A. Ditzen, Dresden; M. Dobonici, Ludwigshafen; U. Eigner, Heidelberg; H. Erichsen, Moers; A. Fahr, Heidelberg; P. Finzer, Moers; U. Frank, Freiburg; A. Friedrich, Münster; C. Freytag, Bad-Oeynhausen; M. Frosch, Würzburg; G. Funke, Ravensburg; S. Gatermann, Bochum; J. Geisen, Köln; W. Hell, Koblenz; M. Herrmann, Homburg; U. Höffler, Ludwigshafen; E. Jacobs, Dresden; B. Jansen, Mainz; D. Jonas, Freiburg; M. Kaase, Bochum; W. Kalka-Moll, Mönchengladbach; M. Kaulfers and J. K. Knobloch, Hamburg; M. Kresken and B. Körber-Irrgang, Rheinbach; M. van der Linden, Aachen; A. Lommel and C. Lücking, Ludwigshafen; D. Mack, Hamburg; S. Monecke, Dresden; S. Müller, Würzburg; L. von Müller, Homburg; A. Müller-Chorus, Bochum; K. Noldt, Hamburg; W. Pfister, Jena; T. Regnath and W. Reiter, Stuttgart; R. R. Reinert, Aachen; J. Rissland, Koblenz; A. Roggenkamp, München; U. Rohr, Bochum; E. Rosenthal, Wiesbaden; S. Schade and S. Scherpe, Hamburg; T. Schmidt-Wieland, Ravensburg; C. Schoerner, Erlangen; S. Schubert, Kiel; R. Schwarz, Köln; R. Schwarz, Mönchengladbach; K. Schwegmann, Hannover; H. Seifert, Köln; V. Simon, München; E. Straube, Jena; M. Trautmann, Stuttgart; U. Ullmann, Kiel; U. Vogel, Würzburg; M. Vogt, Koblenz; H. von Wulffen, Hamburg; T. Wichelhaus, Frankfurt; M. L. Wimmer-Dahmen, Mönchengladbach; J. Wüllenweber, Homburg; B. Würstl, München; and B. Zöllner, Moers. This work was supported in part by the Paul Ehrlich Gesellschaft für Chemotherapie (PEG) (to K. Becker and C. von Eiff) under the auspice of the working group ‘Staphylococcal infections’ of the PEG, and by grants to G. Peters and K. Becker (01KI1014A) within the MedVet-Staph project by the Bundesministerium für Bildung und Forschung (BMBF).

Fingerprint

Dive into the research topics of 'Trends in antimicrobial non-susceptibility in methicillin-resistant Staphylococcus aureus from Germany (2004-2011)'. Together they form a unique fingerprint.

Cite this